Deutsche Bank Ag\ Mirum Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 157,263 shares of MIRM stock, worth $6.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,263

Previous 249,051 36.86%

Holding current value

$6.61 Million

Previous $8.52 Million 27.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$33.68 - $44.74 $3.09 Million - $4.11 Million	-91,788 Reduced 36.86%	157,263 $6.13 Million
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $115,493 - $170,765	4,900 Added 2.01%	249,051 $8.52 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $1.81 Million - $2.18 Million	72,625 Added 42.34%	244,151 $6.13 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $4.27 Million - $5.49 Million	157,162 Added 1094.14%	171,526 $5.06 Million
Q3 2023 Nov 09, 2023	SELL	$24.63 - $32.85 $2.39 Million - $3.19 Million	-97,047 Reduced 87.11%	14,364 $453,000
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $1.13 Million - $1.44 Million	48,020 Added 75.75%	111,411 $2.88 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $81,672 - $102,569	4,256 Added 7.2%	63,391 $1.52 Million
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $899,253 - $1.22 Million	51,123 Added 638.08%	59,135 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $1.36 Million - $2 Million	-68,013 Reduced 89.46%	8,012 $168,000
Q2 2022 Aug 11, 2022	BUY	$18.42 - $27.5 $110,409 - $164,835	5,994 Added 8.56%	76,025 $1.48 Million
Q1 2022 May 13, 2022	SELL	$15.5 - $23.93 $3,720 - $5,743	-240 Reduced 0.34%	70,031 $1.54 Million
Q4 2021 Feb 11, 2022	SELL	$13.05 - $19.35 $127,302 - $188,759	-9,755 Reduced 12.19%	70,271 $1.12 Million
Q3 2021 Nov 04, 2021	SELL	$13.95 - $20.18 $864 - $1,251	-62 Reduced 0.08%	80,026 $1.59 Million
Q2 2021 Aug 11, 2021	SELL	$15.84 - $20.6 $19,594 - $25,482	-1,237 Reduced 1.52%	80,088 $1.39 Million
Q1 2021 May 13, 2021	BUY	$16.29 - $21.92 $155,488 - $209,226	9,545 Added 13.3%	81,325 $1.61 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $1.09 Million - $1.76 Million	69,135 Added 2613.8%	71,780 $1.25 Million
Q3 2020 Nov 12, 2020	BUY	$18.4 - $26.59 $4,636 - $6,700	252 Added 10.53%	2,645 $51,000
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $8,551 - $15,580	743 Added 45.03%	2,393 $47,000
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $7,063 - $17,913	753 Added 83.95%	1,650 $23,000
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $1,265 - $4,791	185 Added 25.98%	897 $21,000
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $6,521 - $10,516	712 New	712 $6,000

Others Institutions Holding MIRM

# of Institutions

190

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.55B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account